等待开盘 05-11 09:30:00 美东时间
+4.110
+3.99%
Mirum stock rises after Phase 2b VISTAS data for volixibat; AZURE-1 results and technical levels highlight momentum and key price zones.
05-04 23:15
- Statistically significant and clinically meaningful 2.72 point reduction from baseline and 1.64 point placebo-adjusted (p=<0.0001) reduction in primary endpoint of cholestatic pruritus- Pre-NDA meeting with the
05-04 20:09
作者:贝壳社 在中国的生物医药版图上,北海康成(1228.HK)是一个独特而矛盾的存在。 2021年12月10日,北海康成在港交所上市,但首个交易日股价跌幅达...
2025-08-14 16:54